These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 15804073)
1. [Serum soluble CD40L level and its application in coronary heart disease]. Li J; Peng DQ; Zhao SP Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):611-4. PubMed ID: 15804073 [TBL] [Abstract][Full Text] [Related]
2. [Changes and relations of soluble plasma CD40L and matrix metalloproteinase-9 levels in patients with coronary heart disease]. Li J; Zhao SP; Peng DQ; Zhou HN Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):517-20. PubMed ID: 16137036 [TBL] [Abstract][Full Text] [Related]
3. Clinical implications of increased expression of CD40L in patients with acute coronary syndromes. Yan J; Wu Z; Huang Z; Li L; Zhong R; Kong X Chin Med J (Engl); 2002 Apr; 115(4):491-3. PubMed ID: 12133281 [TBL] [Abstract][Full Text] [Related]
4. Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome. Yan JC; Wu ZG; Kong XT; Zong RQ; Zhan LZ Acta Pharmacol Sin; 2004 Feb; 25(2):251-6. PubMed ID: 14769218 [TBL] [Abstract][Full Text] [Related]
5. [Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance]. Zhou ZX; Qiang H; Ma AQ; Chen H; Zhou P Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):258-62. PubMed ID: 16706128 [TBL] [Abstract][Full Text] [Related]
6. Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction. Ohashi Y; Kawashima S; Mori T; Terashima M; Ichikawa S; Ejiri J; Awano K Int J Cardiol; 2006 Sep; 112(1):52-8. PubMed ID: 16376442 [TBL] [Abstract][Full Text] [Related]
7. The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes. Yan JC; Zhu J; Gao L; Wu ZG; Kong XT; Zong RQ; Zhan LZ Clin Chim Acta; 2004 May; 343(1-2):155-9. PubMed ID: 15115688 [TBL] [Abstract][Full Text] [Related]
8. Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome. Mälarstig A; Lindahl B; Wallentin L; Siegbahn A Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1667-73. PubMed ID: 16627810 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease. Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363 [TBL] [Abstract][Full Text] [Related]
10. Serum brain-derived neurotrophic factor and platelet activation evaluated by soluble P-selectin and soluble CD-40-ligand in patients with acute myocardial infarction. Lorgis L; Amoureux S; de Maistre E; Sicard P; Bejot Y; Zeller M; Vergely C; Sequeira-Le Grand A; Lagrost AC; Berchoud J; Cottin Y; Rochette L Fundam Clin Pharmacol; 2010 Aug; 24(4):525-30. PubMed ID: 19909348 [TBL] [Abstract][Full Text] [Related]
11. [Serum sCD40L detection for risk evaluation of acute coronary syndromes]. Xu BL; Bei CH; Wang R; Lei XX Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1656-7. PubMed ID: 17121725 [TBL] [Abstract][Full Text] [Related]
12. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease. Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179 [TBL] [Abstract][Full Text] [Related]
13. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease. Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166 [TBL] [Abstract][Full Text] [Related]
14. [Circulating cytokine measurements by protein chips in patients with acute coronary syndrome]. Mao H; Liu TZ; Wen M; Chen JJ; Li L; Zhu JK Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Mar; 36(3):219-22. PubMed ID: 19099977 [TBL] [Abstract][Full Text] [Related]
16. Influence of sample type on soluble CD40 ligand assessment in patients with acute coronary syndromes. Weber M; Rabenau B; Stanisch M; Nef HM; Möllmann H; Elsässer A; Mitrovic V; Heeschen C; Hamm C Thromb Res; 2007; 120(6):811-4. PubMed ID: 17337289 [TBL] [Abstract][Full Text] [Related]
17. Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes. Tousoulis D; Antoniades C; Nikolopoulou A; Koniari K; Vasiliadou C; Marinou K; Koumallos N; Papageorgiou N; Stefanadi E; Siasos G; Stefanadis C Eur J Clin Invest; 2007 Aug; 37(8):623-8. PubMed ID: 17635572 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of OX40-OX40 ligand system on T lymphocytes in patients with acute coronary syndromes. Yan J; Chen G; Gong J; Wang C; Du R J Cardiovasc Pharmacol; 2009 Nov; 54(5):451-5. PubMed ID: 19738490 [TBL] [Abstract][Full Text] [Related]
19. The role of platelets CD40 ligand (CD154) in acute coronary syndromes. Abu el-Makrem MA; Mahmoud YZ; Sayed D; Nassef NM; Abd el-Kader SS; Zakhary M; Ghazaly T; Matta R Thromb Res; 2009 Dec; 124(6):683-8. PubMed ID: 19656553 [TBL] [Abstract][Full Text] [Related]
20. Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina. Kälsch T; Nguyen XD; Elmas E; Grebert N; Süselbeck T; Klüter H; Borggrefe M; Dempfle CE Int J Cardiol; 2006 Aug; 111(2):217-23. PubMed ID: 16182391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]